Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark S Silverberg

Showing results (31-40 of 228) with videos related to

Pageof 23
Sort By:
Inflammatory Bowel Diseases|April 28, 2016
Use of Complementary and Alternative Medicine for Inflammatory Bowel Disease Is Associated with Worse Adherence to Conventional Therapy: The COMPLIANT StudyGeoffrey C Nguyen, Ken Croitoru, Mark S Silverberg, et al.
Arthritis Care & Research|July 22, 2017
Prevalence of Sacroiliitis in Inflammatory Bowel Disease Using a Standardized Computed Tomography Scoring SystemJonathan Chan, Ismail Sari, David Salonen, et al.
European Journal of Gastroenterology & Hepatology|March 18, 2021
Ustekinumab induction concentrations are associated with clinical and biochemical outcomes at week 12 of treatment in Crohn's diseaseMargaret Walshe, Krzysztof Borowski, Karen Boland, et al.
The American Journal of Gastroenterology|July 7, 2011
Celiac disease detected by pouch biopsy of a patient with ileal pouch-anal anastomosisAndrea D Tyler, Travis B Murdoch, Robert H Riddell, et al.
Gut|May 28, 2026
From preclinical phase of Crohn's disease to postoperative recurrence: shared mechanisms and potential interventionsRirong Chen, Williams Turpin, Matthieu Allez, et al.
Scandinavian Journal of Gastroenterology|November 22, 2013
Effect of inflammatory bowel disease therapies on immunogenicity of Mycobacterium paratuberculosis proteinsAnne Xia, Joanne M Stempak, Jesse Grist, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|November 29, 2018
Fecal calprotectin correlates with active colonic inflammatory bowel disease but not with small intestinal Crohn's disease activityEran Zittan, Orlaith B Kelly, Ian M Gralnek, et al.
Inflammatory Bowel Diseases|May 13, 2017
Therapeutic Drug Monitoring to Guide Infliximab Dose Adjustment is Associated with Better Endoscopic Outcomes than Clinical Decision Making Alone in Active Inflammatory Bowel DiseaseOrlaith B Kelly, Sarah Oʼ Donnell, Joanne M Stempak, et al.
European Journal of Gastroenterology & Hepatology|July 29, 2011
Cannabis use amongst patients with inflammatory bowel diseaseSimon Lal, Neeraj Prasad, Manijeh Ryan, et al.
Bioinformatics and Biology Insights|June 14, 2013
Association between a multi-locus genetic risk score and inflammatory bowel diseasePingzhao Hu, Aleixo M Muise, Xiang Xing, et al.
Pageof 23

Showing results (31-40 of 228) with videos related to

Sort By:
Pageof 23
Inflammatory Bowel Diseases|April 28, 2016
Use of Complementary and Alternative Medicine for Inflammatory Bowel Disease Is Associated with Worse Adherence to Conventional Therapy: The COMPLIANT StudyGeoffrey C Nguyen, Ken Croitoru, Mark S Silverberg, et al.
Arthritis Care & Research|July 22, 2017
Prevalence of Sacroiliitis in Inflammatory Bowel Disease Using a Standardized Computed Tomography Scoring SystemJonathan Chan, Ismail Sari, David Salonen, et al.
European Journal of Gastroenterology & Hepatology|March 18, 2021
Ustekinumab induction concentrations are associated with clinical and biochemical outcomes at week 12 of treatment in Crohn's diseaseMargaret Walshe, Krzysztof Borowski, Karen Boland, et al.
The American Journal of Gastroenterology|July 7, 2011
Celiac disease detected by pouch biopsy of a patient with ileal pouch-anal anastomosisAndrea D Tyler, Travis B Murdoch, Robert H Riddell, et al.
Gut|May 28, 2026
From preclinical phase of Crohn's disease to postoperative recurrence: shared mechanisms and potential interventionsRirong Chen, Williams Turpin, Matthieu Allez, et al.
Scandinavian Journal of Gastroenterology|November 22, 2013
Effect of inflammatory bowel disease therapies on immunogenicity of Mycobacterium paratuberculosis proteinsAnne Xia, Joanne M Stempak, Jesse Grist, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|November 29, 2018
Fecal calprotectin correlates with active colonic inflammatory bowel disease but not with small intestinal Crohn's disease activityEran Zittan, Orlaith B Kelly, Ian M Gralnek, et al.
Inflammatory Bowel Diseases|May 13, 2017
Therapeutic Drug Monitoring to Guide Infliximab Dose Adjustment is Associated with Better Endoscopic Outcomes than Clinical Decision Making Alone in Active Inflammatory Bowel DiseaseOrlaith B Kelly, Sarah Oʼ Donnell, Joanne M Stempak, et al.
European Journal of Gastroenterology & Hepatology|July 29, 2011
Cannabis use amongst patients with inflammatory bowel diseaseSimon Lal, Neeraj Prasad, Manijeh Ryan, et al.
Bioinformatics and Biology Insights|June 14, 2013
Association between a multi-locus genetic risk score and inflammatory bowel diseasePingzhao Hu, Aleixo M Muise, Xiang Xing, et al.
Pageof 23